Skip to Main Content

Paper Details

Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients.
Clin Cancer Res
5
2023
Bavituximab, C1, GBM, Glioblastoma, IDH, Immunosuppressive Myeloid-Derived Suppressor Cells, MDSC, Patients, bavituximab, glioblastoma, immunosuppressive MDSCs, inflammatory infiltrates, intratumoral immunosuppressive MDSCs, macrophages, myeloid-derived suppressor cells, myeloid-related gene, myeloid-related genes, myeloid-related transcripts, patients, temozolomide, tumor
Author NameAffiliation
Isabel Arrillaga-RomanyStephen E. and Catherine Pappas Center for Neuro-Oncology Massachusetts General Hospital Cancer Center
Patrick Y WenCenter for Neuro-Oncology, Dana-Farber Cancer Institute
Tracy T BatchelorBrigham and Women's Hospital
Tracy T BatchelorBrigham and Women's Hospital
Jayashree Kalpathy-CramerAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital
  • 1 - 5

Datasets

Release 1.2